Rnai Therapeutics Market Size And Share

  • Report Code : TIPRE00007157
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

RNAi Therapeutics Market Share, Size, and Outlook by 2031

Buy Now

RNAi Therapeutics Market Report RNAi Therapeutics Market Scope and Analysis RNAi Therapeutics Market Size and Share

RNAi Therapeutics Market: Strategic Insights

RNAi Therapeutics Market

  • CAGR (2023 - 2031)
    16.5%
  • Market Size 2021
    US$ 1.5 Billion
  • Market Size 2031
    US$ 3.2 Billion

Market Dynamics

GROWTH DRIVERS
  • RNAi Therapeutics in Cancer Therapy
FUTURE TRENDS
  • Rising Research & Development (R&D) activity
OPPORTUNITIES
  • Imaging Modalities for RNAi Therapeutics for RNAi Therapeutics

Key Players

  • Alnylam Pharmaceuticals Inc
  • Sanofi
  • Olix Pharmaceuticals Inc
  • GlaxoSmithKline Plc
  • Benitec Biopharma
  • Arbutus Biopharma Corporation
  • Silence Therapeutics
  • Rexahn Pharmaceuticals Inc
  • Arrowhead Pharmaceuticals Inc
  • Quark

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Molecule Type
  • Small Interfering RNAs
  • MicroRNA
Application
  • Genetic Disorders
  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular
  • Respiratory Disorders
  • Infectious Diseases
  • Renal Diseases
Route of Administration
  • Intradermal Injections
  • Pulmonary Delivery
  • Intravenous Injections
  • Intraperitoneal Injections
End User
  • Diagnostic Laboratories
  • Research & Academic Laboratories
  • Hospitals